2m 2m 2m 2m 2m 2m 2m
Merck (MRK)
NYSE
$123.94+$0.40 (+0.32%)
Price as of Jul 13, 2026 7:23 PM EDT- $305.1BMarket Cap
- 53.16%1-Year Change
- Drug Manufacturers - GeneralIndustry
Merck (MRK)
$123.94+$0.40 (+0.32%)
MRK | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $123.54 | ||
Change | -$1.53 (-1.22%) | ||
Open | $125.12 | ||
High | $125.56 | ||
Low | $122.90 | ||
Previous Close | $125.07 | ||
Volume | 8,388,686 | ||
30-Day Average Volume | 11,872,759 | ||
1-Week Change | -4.65% | ||
1-Month Change | 4.48% | ||
1-Year Change | 53.16% | ||
3-Year Change | 23.22% | ||
5-Year Change | 85.14% | ||
Fundamentals | |||
Shares Outstanding | 2.5B | ||
Total Assets | $128.7B | ||
Market Cap | $305.1B | ||
Enterprise Value | $348.9B | ||
Period: QTR TTM FY | |||
Revenue | $16.3B | ||
Net Income | -$4.2B | ||
Free Cash Flow | $2.9B | ||
EBIT | -$3.5B | ||
EBITDA | -$3.0B | ||
Net Working Capital | $8.1B | ||
EPS | -$1.72 | ||
Enterprise Value/EBITDA | -118 | ||
Enterprise Value/Revenue | 21 | ||
P/B | 7 | ||
P/E | -72 | ||
PEG | 0 | ||
Price/Free Cash Flow | 104 | ||
Price/Operating Cash Flow | 78 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | 2.75% | ||
Trailing Annual Dividend Yield | 2.72% | ||
Ex-Dividend Date | 06/15/2026 | ||
Last Split Factor | N/A | ||
Last Split Date | N/A | ||
Earnings & Revenue
Annual Dividend Yield